Headerlogotextwithshieldsshadowed

2020 Course Schedule
Critical Issues in Tumor Microenvironment: Angiogenesis, Metastasis and Immunology

Virtual Meeting

Tentative schedule — times subject to change

Monday, October 26, 2020

10:00 A.M.
Opening Remarks Rakesh K. Jain
10:10 A.M.
Tumor Microenvironment I: Angiogenesis and Vascular Function Rakesh K. Jain
10:45 A.M.
Q&A
11:00 A.M.
Break
12:00 P.M.
Tumor Microenvironment II: Vascular Normalization  and Immunotherapy  Rakesh K. Jain
12:45 P.M.
Q&A
1:00 P.M.
Break
2:00 P.M.
Tumor Microenvironment III: Extracellular Matrix, Lymphatics and Metastasis Rakesh K. Jain
2:45 P.M.
Q&A
3:00 P.M.
Break
4:00 P.M.
Cancer Immunology: An Introduction Arlene Sharpe
4:45 P.M.
Q&A
5:00 P.M.
Adjourn

Tuesday, October 27, 2020

10:00 A.M.
Fibroblast Heterogeneity in Solid Tumors: Implications for Pancreatic Cancer David Tuveson
10:45 A.M.
Q&A
11:00 A.M.
Break
12:00 P.M.
Antiangiogenesis and Immune Checkpoint Combinations for the Treatment of Cancer F. Steven Hodi, Jr
12:45 P.M.
Q&A
1:00 P.M.
Break
2:00 P.M.
A Systems Approach to Human Immunology and Tumor Immunity Nir Hacohen
2:45 P.M.
Q&A
3:00 P.M.
Break
4:00 P.M.
Inflammation and Cancer: Response and Resistance Programs Regulated by Leukocytes Lisa M. Coussens
4:45 P.M.
Q&A
5:00 P.M.
Adjourn

Wednesday, October 28, 2020

10:00 A.M.
Determinants of How Tumors Use Metabolism to Support Growth Matthew Vander Heiden
10:45 A.M.
Q&A
11:00 A.M.
Break
12:00 P.M.
Mining the Human Proteome: Biomarker Discovery for Human Cancer and Its Metastases Marsha A. Moses
12:45 P.M.
Q&A
1:00 P.M.
Break
2:00 P.M.
Heterogeneity Through Space and Time Drives the Clinical Behaviour of Childhood Medulloblastoma Michael D. Taylor
2:45 P.M.
Q&A
3:00 P.M.
Break
4:00 P.M.
Dissecting the Tumor Microenvironment using Single-Cell Sequencing Mario Suva
4:45 P.M.
Q&A
5:00 P.M.
Adjourn

Thursday, October 29, 2020

10:00 A.M.
New approaches in imaging and sensing of drug action Ralph Weissleder
10:45 A.M.
Q&A
11:00 A.M.
Break
12:00 P.M.
Mechanisms of Malignant Progression Robert A. Weinberg
12:45 P.M.
Q&A
1:00 P.M.
Break
2:00 P.M.
Lessons from Clinical Trials of Targeted Therapies for Cancer George W. Sledge, Jr
2:45 P.M.
Q&A
3:00 P.M.
Break
4:00 P.M.
Circadian clock and Tumor Metabolic Vulnerabilities Chi Van Dang
4:45 P.M.
Q&A
5:00 P.M.
Summary and closing remarks Rakesh K. Jain